|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Coxsackievirus IgG ELISA | APP-Beta-CTF ELISA Assay | CA 242 ELISA Assay | Complement C4d ELISA | Gd-IgA1 (Galactose-deficient IgA1) ELISA |
| Citations | | | | | |
| Catalog Number | IB05040 | 27776 | 101-85 | COMPL C4d RUO | 27600 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgG antibodies directed against Coxsackie viruses in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human APP ßCTF in cell lysate. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of CA 242 cancer antigen in serum. For research use only, not for use in diagnostic procedures. Please note this assay has a 5 kit purchase minimum. | The Complement C4d assay is an enzyme-linked immunosorbent assay (ELISA) for the semiquantitative determination of C4d in human plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More |
| Detection Target | Coxsackievirus IgG | Clostridium tetani toxin IgG | Complement Factor P (Properdin) | Phospho Tau (181P) | Metanephrine / Normetanephrine |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum, Blood Plasma | Human serum or EDTA plasma. | Cerebrospinal fluids | Urine |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 0.19 to 12 pmol/L | 15 to 150 U/mL | 0 / 5 - 400 ng/mL | 1.56 to 100.0 ng/mL |
| Sensitivity | > 90% | 99.22% (95% confidence interval: 95.76% - 99.98%) | Inquire | 1.9 pg/mL | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | Overnight + 1 hr 30 mins (incubation) | 3 hrs 30 mins (incubation) | 2 hours total incubation time. | 2 hours (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |